| P2093 | author name string | George Hui | |
| | Kae Pusic | |
| | Sophie Kobuch | |
| | Danielle Clements | |
| P2860 | cites work | Cell lines derived from late embryonic stages of Drosophila melanogaster | Q52834135 |
| | Merozoite surface proteins of the malaria parasite: The MSP1 complex and the MSP7 family | Q21147068 |
| | T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines | Q28740432 |
| | The importance of human FcgammaRI in mediating protection to malaria | Q33285037 |
| | Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses | Q33356029 |
| | Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus | Q33605280 |
| | Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. | Q34003987 |
| | Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial | Q34006332 |
| | Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine | Q34011922 |
| | Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum | Q34298109 |
| | Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity | Q34975629 |
| | A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. | Q35463512 |
| | Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge | Q35557454 |
| | Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination | Q36045018 |
| | Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. | Q36368911 |
| | The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine | Q36398927 |
| | Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine | Q36412687 |
| | Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum | Q36943106 |
| | Plasmodium falciparum malaria vaccines in development | Q37103927 |
| | The future for blood-stage vaccines against malaria | Q37471465 |
| | The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody | Q37483845 |
| | Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure | Q37502907 |
| | Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype. | Q38938580 |
| | A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth | Q38938589 |
| | Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts | Q39085980 |
| | Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae | Q39086004 |
| | Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. | Q39086032 |
| | In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system | Q39655089 |
| | Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria | Q41028358 |
| | A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii | Q42074466 |
| | The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. | Q42937100 |
| | Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with a | Q44078968 |
| | Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa | Q47309532 |
| | Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro | Q47845842 |
| | Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP1(33). | Q47860963 |
| | Identification of frequently recognized dimorphic T-cell epitopes in plasmodium falciparum merozoite surface protein-1 in West and East Africans: lack of correlation of immune recognition and allelic prevalence | Q47886473 |
| | Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites | Q47902824 |
| | Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli | Q47998752 |
| | Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. | Q47999462 |
| | Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese vi | Q48000659 |
| | Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance | Q48008382 |
| | Malaria parasites and erythrocyte invasion | Q48010313 |
| | Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). | Q48024331 |
| | Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity | Q48027524 |
| | Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. | Q48030282 |
| | Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains | Q48202726 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e75939 | |
| P577 | publication date | 2013-09-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccines | |
| P478 | volume | 8 | |